Niva Bupa Health Insurance Company Limited has announced its quarterly earnings conference call with analysts and investors, scheduled for January 29, 2026, at 6:30 PM IST. The company informed stock exchanges about this development through a regulatory filing dated January 21, 2026, under Regulation 30 of SEBI listing requirements.

Conference Call Details

The earnings call will focus on discussing the company's performance for the quarter and nine months ended December 31, 2025. ICICI Securities will coordinate the conference call, providing multiple access options for participants.

Management Representation

The company will be represented by its senior leadership team during the earnings call:

• Krishnan Ramachandran - Managing Director & CEO
• Vishwanath Mahendra - Executive Director & CFO
• Ankur Kharbanda - Executive Director & Chief Business Officer
• Bhabatosh Mishra - Chief Operating Officer
• Vikas Jain - Chief Investment Officer

Access Information

Participants can join the conference call through multiple channels:

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Executive Director and CFO Vishwanath Mahendra signed the regulatory filing on behalf of the company. The company maintains its registered office at C-98, First Floor, Lajpat Nagar, Part 1, Delhi-110024, and operates under IRDAI Registration No. 145.

Niva Bupa Health Insurance Company has reported a remarkable 53% year-on-year increase in premium revenue, demonstrating strong business performance in the health insurance sector. This substantial growth reflects the company's expanding market presence and successful customer acquisition strategies.

Financial Performance Highlights

The company's premium revenue growth of 53% year-on-year represents a significant milestone in its business trajectory. This performance indicates robust demand for the company's health insurance products and services.

Market Position and Growth

The substantial revenue increase positions Niva Bupa Health Insurance Company favorably within the competitive health insurance landscape. This growth trajectory suggests effective business strategies and strong market acceptance of the company's insurance offerings.

The 53% year-on-year premium revenue growth demonstrates the company's ability to capitalize on the expanding health insurance market in India. This performance reflects both organic growth and the company's strategic initiatives to enhance its market share.

Business Implications

The significant premium revenue growth indicates several positive business developments for the company. Strong revenue performance typically reflects increased policy sales, customer retention, and effective pricing strategies in the health insurance segment.

This growth rate substantially exceeds typical industry benchmarks, suggesting that Niva Bupa Health Insurance Company has successfully differentiated its offerings and captured market opportunities effectively.